2012-26994. Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting
-
Start Preamble
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
Name of Committee: National Science Advisory Board for Biosecurity.
Date: November 27, 2012.
Time: 11:00 a.m. to 3:00 p.m. Eastern Time (Times are approximate and subject to change).
Agenda: Presentations and discussions regarding: (1) A proposed framework for guiding HHS funding decisions on HPAI H5N1 gain-of-function research; (2) report of the NSABB Working Group on Global Engagement; and (3) other business of the Board.
Place: National Institutes of Health, Building 31, 6th Floor, Room 6, Bethesda, Maryland 20892.
Contact Person: Ronna Hill, NSABB Program Assistant, NIH Office of Biotechnology Activities, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892, (301) 496-9838, hillro@od.nih.gov.
Submitted Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established the NSABB to provide advice regarding federal oversight of dual use research, defined as biological research that generates information and technologies that could be misused to pose a biological threat to public health and/or national security.
The meeting will be open to the public, however pre-registration is strongly recommended due to space limitations. Persons planning to attend should register online at: http://oba.od.nih.gov/biosecurity/biosecurity_meetings.html or by calling Palladian Partners, Inc. (Contact: Joel Yaccarino at 301-650-8660). Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate these requirements upon registration.
This meeting will also be webcast. To access the webcast, as well as the draft meeting agenda and preregistration information, connect to: http://oba.od.nih.gov/biosecurity/biosecurity_meetings.html. Please check this site for updates.
Any member of the public interested in presenting oral comments relevant to the mission of the NSABB at the open meeting should notify the Contact Person listed on this notice. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments relevant to the mission of the NSABB. All written comments should be sent via email to the Contact Person listed on this notice. The written comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the commenter.
Start SignatureDated: October 31, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-26994 Filed 11-5-12; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Comments Received:
- 0 Comments
- Effective Date:
- 11/27/2012
- Published:
- 11/06/2012
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2012-26994
- Dates:
- November 27, 2012.
- Pages:
- 66624-66624 (1 pages)
- PDF File:
- 2012-26994.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute